Journal
EXPERIMENTAL CELL RESEARCH
Volume 317, Issue 7, Pages 932-940Publisher
ELSEVIER INC
DOI: 10.1016/j.yexcr.2011.01.025
Keywords
PI3K/Akt pathway; Apoptosis; LY294002; NF-kappa B; PKHD1
Categories
Funding
- Shenzhen Science and Technology Plan [200802092]
- PKD Foundation
- National Institutes of Health [P50DK074030]
Ask authors/readers for more resources
Mutations in PKHD1 (polycystic kidney and hepatic disease gene 1) gene cause the autosomal recessive polycystic kidney disease (ARPKD). Fibrocystin/polyductin (FPC), encoded by PKHD1, is a membrane-associated receptor-like protein. Although it is widely accepted that cystogenesis is mostly due to aberrant cell proliferation and apoptosis, it is still unclear how apoptosis is regulated. The aim of this study is to analyze the relationship among apoptosis, phosphatidylinositol 3-kinase (PI3K)/Akt and nuclear factor kappa B (NF-kappa B) in FPC knockdown kidney cells. We show that PIGLID1-silenced HEK293 cells demonstrate a higher PI3K/Akt activity. Selective inhibition of PI3K/Akt using LY294002 or wortmannin in these cells increases serum starvation-induced HEK293 cell apoptosis with a concomitant decrease in cell proliferation and higher caspase-3 activity. PI3K/Akt inhibition also leads to increased NF-kappa B activity in these cells. We conclude that the PI3K/Akt pathway is involved in apoptotic function in PKHD1-silenced cells, and PI3K/Akt inhibition correlates with upregulation of NF-kappa B activity. These observations provide a potential platform for determining FPC function and therapeutic investigation of ARPKD. (C) 2011 Elsevier Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available